Research Article

Recombinant Production of E. coli NAD+-dependent DNA ligase as a Target for Antibacterial Drug Discovery

Volume: 25 Number: 1 February 28, 2022
TR EN

Recombinant Production of E. coli NAD+-dependent DNA ligase as a Target for Antibacterial Drug Discovery

Abstract

The increase in the frequency of drug resistance in bacterial infections has led to the research of new antibacterial agents targeting new mechanisms. Many of the functions of NAD+-dependent DNA ligase have made it a remarkable target for antibacterial drug discovery. Escherichia coli (E. coli) NAD+-dependent DNA ligase is presented as a potential target due to its unique substrate specificity compared to the ATP-dependent human DNA ligase. In this study, it was aimed to produce and purify the E. coli NAD + dependent DNA ligase enzyme, which is frequently used in antibacterial drug discovery. The E. coli DNA ligase gene sequence was cloned into pTOLT vector system. E. coli DNA ligase enzyme was purified after the production in E. coli BL21 (DE3) pLysE cells. It was clearly demonstrated by the activity test that the DNA ligase enzyme produced in this study can ligate the DNA fragments. As a result, it was revealed that the effect of candidate inhibitors can be studied simply on the enzyme.

Keywords

Supporting Institution

Turkish Scientific and Technical Research Council (TUBITAK)

Project Number

2209-A

Thanks

This study was supported by the Turkish Scientific and Technical Research Council (TUBITAK) (TUBITAK-2209A)

References

  1. Alomari A, Allen, M 2019. Clone, purify and 1D Nuclear Magnetic Resonance Spectroscopy of the BRCT Domain of E. coli DNA Ligase LigA. Iraqi Journal of Biotechnologies 18, 2.
  2. Anderluh G, Gokce I, Lakey JH 2003. Expression of proteins using the third domain of the Escherichia coli periplasmic-protein TolA as a fusion partner. Protein Expr Purif 28:173-181. doi:10.1016/s1046-5928(02)00681-2.
  3. Brotz-Oesterhelt H, Knezevic I, Bartel S, Lampe T, Warnecke-Eberz U, Ziegelbauer K, Habich D, Labischinski H 2003. Specific and potent inhibition of NAD+-dependent DNA ligase by pyridochromanones. J Biol Chem 278:39435-39442. doi:10.1074/jbc.M306479200.
  4. Cardona-Felix CS, Pastor-Palacios G, Cardenas H, Azuara-Liceaga E, Brieba LG 2010. Biochemical characterization of the DNA ligase I from Entamoeba histolytica. Mol Biochem Parasitol 174:26-35. doi:10.1016/j.molbiopara.2010.06.010.
  5. Crut A, Nair PA, Koster DA, Shuman S, Dekker NH 2008. Dynamics of phosphodiester synthesis by DNA ligase. Proc Natl Acad Sci U S A 105:6894-6899. doi:10.1073/pnas.0800113105.
  6. Dermody JJ, Robinson GT, Sternglanz R 1979. Conditional-lethal deoxyribonucleic acid ligase mutant of Escherichia coli. J Bacteriol 139:701-704.
  7. Doherty AJ, Ashford SR, Wigley DB 1996. Characterization of proteolytic fragments of bacteriophage T7 DNA ligase. Nucleic Acids Res 24:2281-2287. doi:10.1093/nar/24.12.2281.
  8. Dwivedi N, Dube D, Pandey J, Singh B, Kukshal V, Ramachandran R, Tripathi RP (2008) NAD(+)-dependent DNA ligase: a novel target waiting for the right inhibitor. Med Res Rev 28:545-568. doi:10.1002/med.20114.

Details

Primary Language

English

Subjects

-

Journal Section

Research Article

Publication Date

February 28, 2022

Submission Date

February 21, 2021

Acceptance Date

April 20, 2021

Published in Issue

Year 2022 Volume: 25 Number: 1

APA
Kaplan, Ö., İmamoğlu, R., & Gökçe, İ. (2022). Recombinant Production of E. coli NAD+-dependent DNA ligase as a Target for Antibacterial Drug Discovery. Kahramanmaraş Sütçü İmam Üniversitesi Tarım Ve Doğa Dergisi, 25(1), 19-24. https://doi.org/10.18016/ksutarimdoga.vi.884279

Cited By


International Peer Reviewed Journal
Free submission and publication
Published 6 times a year



88x31.png


KSU Journal of Agriculture and Nature

e-ISSN: 2619-9149